James Hardie Finalizes Executive Compensation Redesign and New CEO Equity Grant After Shareholder Rejection
JHX sits 56% above its 52-week low of $16.46.
Summary
James Hardie is seeking shareholder approval for a redesigned executive compensation plan and a new CEO equity grant, following previous shareholder rejection of its remuneration report and a CEO equity award.
Key Events · Corporate Governance and Compliance · JHX
-
Executive Compensation Overhaul
The company finalized a redesigned FY27 executive compensation program, including reduced maximum payouts and a shift from cash-settled to equity-settled long-term incentives, in response to prior shareholder dissent.
-
CEO Equity Grant Proposal
Shareholders will vote on a new $6.1 million equity grant for CEO Aaron Erter, which includes PRSUs, RSUs, and stock options, following the rejection of his FY26 ROCE PRSU award.
-
Negative Discretion on FY26 Payouts
The People & Compensation Committee applied significant negative discretion to FY26 executive compensation, resulting in the CEO's Short-Term Incentive paying out at 48% of target and 0% vesting for TSR PRSUs.
-
Non-Executive Director Fee Pool Increase
A proposal seeks to increase the maximum aggregate non-executive director fee pool by $700,000, from $3.8 million to $4.5 million, citing increased duties, regulatory burdens, and tax equalization payments.
Analysis · JHX · Manufacturing
This definitive proxy statement outlines significant changes to James Hardie's executive compensation program for FY27, directly addressing the rejection of the FY25 Remuneration Report and a CEO equity grant by shareholders. The company applied substantial negative discretion to FY26 executive payouts, resulting in the CEO's Short-Term Incentive paying out at 48% of target and 0% vesting for TSR PRSUs. The new FY27 plan introduces a simplified structure with reduced maximum payouts, removes cash-settled long-term incentives, and incorporates more time-based RSUs and stock options. Shareholders will vote on a new $6.1 million equity grant for the CEO and a $700,000 increase to the non-executive director fee pool. These proposals are critical for aligning executive incentives with shareholder interests and improving corporate governance following past dissent.
At the time of this filing, JHX was trading at $25.69 on NYSE in the Manufacturing sector, with a market capitalization of approximately $14.9B. The 52-week trading range was $16.46 to $29.83. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.